FALCO HOLDINGS Co., Ltd. (4671.T)
JPY 2231.0
(-0.4%)
JPY 2231.0
(-0.4%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.66 Billion JPY | -26.32% |
| 2022 | 2.26 Billion JPY | -36.0% |
| 2021 | 3.53 Billion JPY | 90.66% |
| 2020 | 1.85 Billion JPY | 49.07% |
| 2019 | 1.24 Billion JPY | 90.35% |
| 2018 | 653 Million JPY | -61.52% |
| 2017 | 1.69 Billion JPY | 14.82% |
| 2016 | 1.47 Billion JPY | 9.73% |
| 2015 | 1.34 Billion JPY | 20.59% |
| 2014 | 1.11 Billion JPY | -50.97% |
| 2013 | 2.27 Billion JPY | 76.59% |
| 2012 | 1.29 Billion JPY | 88.87% |
| 2011 | 683 Million JPY | -28.11% |
| 2010 | 950 Million JPY | 0.0% |
| 2009 | - JPY | -100.0% |
| 2008 | 115 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 262 Million JPY | -32.99% |
| 2023 Q4 | 391 Million JPY | -39.47% |
| 2023 Q3 | 646 Million JPY | 27.92% |
| 2023 Q2 | 505 Million JPY | 307.26% |
| 2023 Q1 | 124 Million JPY | -82.8% |
| 2023 FY | 1.66 Billion JPY | -26.32% |
| 2022 FY | 2.26 Billion JPY | -36.0% |
| 2022 Q3 | 415 Million JPY | -39.24% |
| 2022 Q1 | 442 Million JPY | -56.24% |
| 2022 Q2 | 683 Million JPY | 54.52% |
| 2022 Q4 | 721 Million JPY | 73.73% |
| 2021 Q3 | 398 Million JPY | -68.91% |
| 2021 Q1 | 845 Million JPY | -8.94% |
| 2021 FY | 3.53 Billion JPY | 90.66% |
| 2021 Q2 | 1.28 Billion JPY | 51.48% |
| 2021 Q4 | 1.01 Billion JPY | 153.77% |
| 2020 Q3 | 588 Million JPY | 0.17% |
| 2020 Q2 | 587 Million JPY | 334.8% |
| 2020 Q4 | 928 Million JPY | 57.82% |
| 2020 FY | 1.85 Billion JPY | 49.07% |
| 2020 Q1 | -250 Million JPY | -67.79% |
| 2019 Q3 | 1.11 Billion JPY | 1473.24% |
| 2019 Q1 | 204 Million JPY | 198.08% |
| 2019 FY | 1.24 Billion JPY | 90.35% |
| 2019 Q4 | -149 Million JPY | -113.34% |
| 2019 Q2 | 71 Million JPY | -65.2% |
| 2018 Q3 | 335 Million JPY | 5.35% |
| 2018 FY | 653 Million JPY | -61.52% |
| 2018 Q4 | -208 Million JPY | -162.09% |
| 2018 Q2 | 318 Million JPY | 52.88% |
| 2018 Q1 | 208 Million JPY | -57.2% |
| 2017 Q4 | 486 Million JPY | 15.17% |
| 2017 Q1 | 354 Million JPY | -23.87% |
| 2017 Q3 | 422 Million JPY | -2.99% |
| 2017 Q2 | 435 Million JPY | 22.88% |
| 2017 FY | 1.69 Billion JPY | 14.82% |
| 2016 Q4 | 465 Million JPY | 37.17% |
| 2016 Q2 | 472 Million JPY | 133.66% |
| 2016 Q3 | 339 Million JPY | -28.18% |
| 2016 Q1 | 202 Million JPY | -51.33% |
| 2016 FY | 1.47 Billion JPY | 9.73% |
| 2015 Q1 | 316 Million JPY | 9.72% |
| 2015 Q3 | 398 Million JPY | 82.57% |
| 2015 Q2 | 218 Million JPY | -31.01% |
| 2015 FY | 1.34 Billion JPY | 20.59% |
| 2015 Q4 | 415 Million JPY | 4.27% |
| 2014 Q3 | 388 Million JPY | 107.49% |
| 2014 Q4 | 288 Million JPY | -25.77% |
| 2014 FY | 1.11 Billion JPY | -50.97% |
| 2014 Q1 | 254 Million JPY | 181.94% |
| 2014 Q2 | 187 Million JPY | -26.38% |
| 2013 Q2 | 214 Million JPY | -51.03% |
| 2013 FY | 2.27 Billion JPY | 76.59% |
| 2013 Q1 | 437 Million JPY | -3.32% |
| 2013 Q3 | 1.93 Billion JPY | 805.14% |
| 2013 Q4 | -310 Million JPY | -116.0% |
| 2012 Q3 | 389 Million JPY | 108.02% |
| 2012 FY | 1.29 Billion JPY | 88.87% |
| 2012 Q2 | 187 Million JPY | -28.63% |
| 2012 Q1 | 262 Million JPY | 175.79% |
| 2012 Q4 | 452 Million JPY | 16.2% |
| 2011 FY | 683 Million JPY | -28.11% |
| 2011 Q2 | 244 Million JPY | -11.27% |
| 2011 Q4 | 95 Million JPY | 37.68% |
| 2011 Q3 | 69 Million JPY | -71.72% |
| 2011 Q1 | 275 Million JPY | 9.56% |
| 2010 FY | 950 Million JPY | 0.0% |
| 2010 Q3 | 296 Million JPY | -22.51% |
| 2010 Q2 | 382 Million JPY | 1810.0% |
| 2010 Q1 | 20 Million JPY | 0.0% |
| 2010 Q4 | 251 Million JPY | -15.2% |
| 2009 Q3 | 79 Million JPY | 0.0% |
| 2009 FY | - JPY | -100.0% |
| 2009 Q4 | - JPY | -100.0% |
| 2008 Q3 | -100 Million JPY | 0.0% |
| 2008 Q4 | 49 Million JPY | 149.0% |
| 2008 FY | 115 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Shin Nippon Biomedical Laboratories, Ltd. | 5.53 Billion JPY | 69.88% |
| DNA Chip Research Inc. | -248.29 Million JPY | 770.981% |
| Cosmo Bio Company,Limited | 442 Million JPY | -276.923% |
| H.U. Group Holdings, Inc. | -7.55 Billion JPY | 122.057% |
| BML, Inc. | 6.03 Billion JPY | 72.39% |
| Human Metabolome Technologies, Inc. | 243.24 Million JPY | -584.898% |
| Precision System Science Co., Ltd. | -1.12 Billion JPY | 248.554% |